Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Allergy Thera. (AGY) Share News

IN BRIEF: Allergy Therapeutics amends facility, plans warrant issue

27th Dec 2023 14:17

Allergy Therapeutics PLC - Sussex-based biotechnology company specialising in allergy vaccines - Shares rise as firm enters amendment to the facility agreement it reached in early April with SkyGem Acquisition Ltd and Southern Fox Investments Ltd. Deal provides Allergy Therapeutics with a GBP40 million secured loan facility of which GBP32.5 million is uncommitted. Facility is available to drawdown between January 15 and the same day in 2026, with interest payable semi-annually at 12% per year and a January 15, 2027 repayment date. Read More

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

15th Dec 2023 21:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Allergy Therapeutics shares jump as hails grass allergy jab data

13th Dec 2023 10:11

(Alliance News) - Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the product closer to market entry. Read More

AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer

13th Dec 2023 09:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

11th Dec 2023 07:41

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite. Read More

Allergy Therapeutics says allergy therapy trial meets primary endpoint

14th Nov 2023 11:56

(Alliance News) - Allergy Therapeutics PLC on Tuesday said that a trial evaluating the efficacy of its subcutaneous allergen-specific immunotherapy candidate has met its primary endpoint. Read More

AIM WINNERS & LOSERS: Renalytix revenue halves; DP Poland trades well

14th Nov 2023 10:59

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

IN BRIEF: Allergy Therapeutics extends cash runway until end of 2023

6th Nov 2023 12:33

Allergy Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Says it continued to work on initiatives to improve cost control and manage working capital alongside trading broadly in line with expectations for the current financial year to date. Says it has extended its cash runway and anticipates to require additional funding by the end of December. Further, says discussions with some major shareholders regarding a subscription and open offer announced in October have progressed. Says that the pivotal phase 3 grass G306 modified allergen tyrosine adsorbed monophosphoryl lipid A trial remains on track to report interim results this month. Via G306, the company aims to release an immunotherapy for grass allergy. Read More

ZQ makes mandatory offer for Allergy Therapeutics as holding hits 60%

16th Oct 2023 08:40

(Alliance News) - ZQ Capital Management Ltd on Monday announced a mandatory takeover offer for Allergy Therapeutics PLC, as required under UK takeover rules, but it said the offer won't be accepted by the Allergy's second largest shareholder and so won't succeed. Read More

IN BRIEF: Allergy Therapeutics raises GBP40.8 million in fundraise

13th Oct 2023 14:07

Allergy Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Says that it has conditionally raised total gross proceeds of approximately GBP40.8 million through an equity financing, which was announced on April 6. Proceeds of the equity financing will be used to repay amounts owed under the loan facility agreement. Read More

EARNINGS: Safestyle suffers amid "difficult" trading conditions

27th Sep 2023 13:10

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Cohort trading ahead of expectations, record orders

26th Sep 2023 19:38

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Braemar investigation to end; Marula reports delay

22nd Sep 2023 20:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday, Thursday and Wednesday and not separately reported by Alliance News: Read More

Allergy Therapeutics shares plunge on expected loss and revenue drop

10th Aug 2023 11:11

(Alliance News) - Allergy Therapeutics PLC on Thursday said it expects to swing to a loss for the full-year as revenue plummets on production disruptions. Read More

Allergy Therapeutics appoints new CFO; interim CFO to leave in August

10th Jul 2023 13:45

(Alliance News) - Allergy Therapeutics PLC on Monday said it has promoted Group Financial Controller Shaun Furlong to chief financial officer. Read More

Allergy Therapeutics banks on second half-year to boost revenue

19th Jun 2023 11:40

(Alliance News) - Allergy Therapeutics PLC on Monday said its loss widened and revenue fell, with costs going up as new research studies progress, but predicted improved sales in the second half of the year thanks to higher demand in the seasonal allergy market. Read More

FTSE 100 Latest

Value8,809.74

Change53.53